-
The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
-
Chun-Shih Chin
Yen-Hsiang Huang
Tsung-Ying Yang
Sung-Liang Yu
Kuo-Hsuan Hsu
Kun-Chieh Chen
Kang-Yi Su
Jeremy J.W. Chen
Jeng-Sen Tseng
Gee-Chen Chang
대한암학회[2022]
Google Scholar네이버 전문정보
|
|
|
|
